Daniel Hodson, PhD, MRCP, FRCPath

Pathogenesis of Aggressive B Cell Lymphoma

We seek to understand how the control systems of normal cells become corrupted during the process of lymphoma development. In doing so, we aim to identify cancerous pathways that can be inhibited by novel drugs in a way that specifically targets the cancerous cells while leaving normal cells intact.